Bactiguard enters exclusive distribution agreement with Cadila Pharmaceuticals


Swedish firm offers full range of infection prevention products

Bactiguard, a Swedish supplier of antimicrobial products, has signed an exclusive co-operation with Cadila Pharmaceuticals, one of the largest healthcare manufacturing groups in India.

Under the agreement, Cadila will sell Bactiguard\'s products throughout India.

The Indian medical device market is currently worth approximately US$2bn and is growing by 15% annually, said Bactiguard.

“For Bactiguard this is a milestone. India is one of the world\'s most interesting and fastest growing markets right now, and we are proud to be able to help India with our expertise in the field of infection protection,” said Christian Kinch, chief executive of Bactiguard.

“We are hoping to reduce the number of hospital acquired infections and thereby also reduce the use of antibiotics in India together with Cadila.”

Dr Rajiv Modi, managing director of Cadila Pharmaceuticals of Ahmedabad, said hospital acquired infections were a big problem for patients in India and he is confident that Indian hospitals would embrace Bactiguard’s clinically proven solution.

The Bactiguard technology consists of an extremely thin noble metal coating, with antimicrobial and biocompatible properties that can be used on all sorts of medical devices.

The Bactiguard coated urinary catheter has since 1995 been used by more than 110 million patients in the US. The firm now offers a full portfolio within infection prevention in the urinary tract, respiratory tract and blood stream.